Milestone Scientific Inc. (NASDAQ:MLSS) issued its earnings results on Thursday. The company reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by $0.03. The business had revenue of $3.19 million for the quarter, compared to analysts’ expectations of $2.69 million.

Shares of Milestone Scientific (NASDAQ:MLSS) opened at 2.05 on Thursday. The firm has a 50-day moving average of $1.94 and a 200-day moving average of $2.37. The firm’s market cap is $55.88 million. Milestone Scientific has a 12 month low of $1.15 and a 12 month high of $3.20.

Milestone Scientific Company Profile

Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.

5 Day Chart for NASDAQ:MLSS

Receive News & Stock Ratings for Milestone Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific Inc. and related stocks with our FREE daily email newsletter.